Showing 1 - 5 results of 5 for search 'Satoko Matsueda', query time: 0.03s Refine Results
  1. 1
    Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue

    Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue by Yoshimi Arima, Satoko Matsueda, Hideyuki Saya

    Published 2023-04-01
    Get full text
    Article
  2. 2
    Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling

    Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling by Song Liu, Satoko Matsueda, Takaaki Oba, Fumito Ito, Kenichi Makino, Ryutaro Kajihara, Mark D Long, Kazunori Kanehira

    Published 2022-01-01
    Get full text
    Article
  3. 3
    Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8+ T cells: implication for cancer immunotherapy.

    Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8+ T cells: implication for cancer immunotherapy. by Mingjun Wang, Bingnan Yin, Satoko Matsueda, Lijuan Deng, Ying Li, Wei Zhao, Jia Zou, Qingtian Li, Christopher Loo, Rong-Fu Wang, Helen Y Wang

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy.

    Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy. by Satoko Matsueda, Mingjun Wang, Jinsheng Weng, Ying Li, Bingnan Yin, Jia Zou, Qingtian Li, Wei Zhao, Weiyi Peng, Xavier Legras, Christopher Loo, Rong-Fu Wang, Helen Y Wang

    Published 2012-01-01
    Get full text
    Article
  5. 5
    EGFR T790M mutation as a possible target for immunotherapy; identification of HLA-A*0201-restricted T cell epitopes derived from the EGFR T790M mutation.

    EGFR T790M mutation as a possible target for immunotherapy; identification of HLA-A*0201-restricted T cell epitopes derived from the EGFR T790M mutation. by Teppei Yamada, Koichi Azuma, Emi Muta, Jintaek Kim, Shunichi Sugawara, Guang Lan Zhang, Satoko Matsueda, Yuri Kasama-Kawaguchi, Yuichi Yamashita, Takuto Yamashita, Kazuto Nishio, Kyogo Itoh, Tomoaki Hoshino, Tetsuro Sasada

    Published 2013-01-01
    Get full text
    Article

Search Tools: